Federated Hermes’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Federated Hermes’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,098	Closed	-$4K	–	2269
2016 Q1	$4K	Hold	9,098	–	–	﹤0.01%	1925
2015 Q4	$6K	Hold	9,098	–	–	﹤0.01%	1863
2015 Q3	$9K	Hold	9,098	–	–	﹤0.01%	1736
2015 Q2	$11K	Hold	9,098	–	–	﹤0.01%	1720
2015 Q1	$10K	Hold	9,098	–	–	﹤0.01%	1787
2014 Q4	$10K	Hold	9,098	–	–	﹤0.01%	1751
2014 Q3	$10K	Buy	+9,098	New	+$11.2K	﹤0.01%	1743

Other funds holding ENZN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

OSAM

O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MCM

Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return

CFA

CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Federated Hermes's ENZN Position: Q2 2016 in Review

Federated Hermes sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 9,098 shares — an estimated $4K sold.

Federated Hermes first reported a position in ENZN in Q3 2014 and held it in 7 quarters. The position peaked at $11K in Q2 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

Federated Hermes reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
Federated Hermes sold 9,098 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $4K.
Federated Hermes first reported a position in ENZON PHARMACEUTICALS INC in Q3 2014 and held it in 7 quarters.
Federated Hermes's ENZON PHARMACEUTICALS INC position peaked at $11K in Q2 2015.
10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Federated Hermes's 13F filing for Q2 2016, filed 12 Aug 2016.